Comments
In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we are enclosing herewith Un-audited Financial Results for the quarter ended June 30, 2019 along with Limited Review Report of the said period in the prescribed form which have been taken on record and approved by the Board of Directors of the Company in its meeting held today i.e. July 26, 2019 at Mumbai. Kindly note that meeting of Board of Directors commenced at 3.00 P.M. and concluded at 4:40 P.M. Further please note that the Company has made necessary arrangement to publish the same in newspapers as required under Listing Regulations. We request you to take the same on your records.
Pdf Link: Mangalam Drugs & Organics Ltd. - Un-Audited Financial Results For The Quarter Ended June 30, 2019.
Source : BSE - www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.